{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:33:08Z","timestamp":1791109988613,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1007\/bf02988596","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T07:11:51Z","timestamp":1226733111000},"page":"85-92","source":"Crossref","is-referenced-by-count":167,"title":["Cerebral blood flow and metabolic abnormalities in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Hiroshi","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02988596_CR1","first-page":"1579","volume":"33","author":"S Minoshima","year":"1992","unstructured":"Minoshima S, Berger KL, Lee KS, Mintun MA. An automated method for rotational correction and centering of three-dimensional functional brain images.J Nucl Med 1992; 33: 1579\u20131585.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR2","first-page":"322","volume":"34","author":"S Minoshima","year":"1993","unstructured":"Minoshima S, Koeppe RA, Mintun MA, et al. Automated detection of the intercommissural (AC-PC) line for stereotactic localization of functional brain images.J Nucl Med 1993; 34: 322\u2013329.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR3","first-page":"1528","volume":"35","author":"S Minoshima","year":"1993","unstructured":"Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomical standardization: linear scaling and nonlinear warping of functional brain images.J Nucl Med 1993; 35: 1528\u20131537.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR4","first-page":"3","volume-title":"Human Brain Function","author":"CD Frith","year":"1997","unstructured":"Frith CD, Friston KJ, Ashburner J, et al. Principles and methods. InHuman Brain Function, Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC (eds), 1st ed, San Diego; Academic Press, 1997: 3\u2013159.","edition":"1st ed"},{"key":"BF02988596_CR5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archneur.57.4.454","volume":"57","author":"G Emilinen","year":"2000","unstructured":"Emilinen G, Beyreuther K, Masters CL, Maloteaux JM, Prospects for pharmacological intervention in Alzheimer disease.Arch Neurol 2000; 57: 454\u2013459.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","volume":"7","author":"RP Friedland","year":"1983","unstructured":"Friedland RP, Budinger TF, Ganz E, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.J Comput Assist Tomogr 1983; 7: 590\u2013598.","journal-title":"J Comput Assist Tomogr"},{"key":"BF02988596_CR7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.33.8.961","volume":"33","author":"NL Foster","year":"1983","unstructured":"Foster NL, Chase TN, Fedio P, Psztonas NJ, Brooks RA, Di Chiro G. Alzheimer\u2019s disease: focal cortical changes shown by positron emission tomography.Neurology 1983; 33: 961\u2013965.","journal-title":"Neurology"},{"key":"BF02988596_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiology.150.3.6607481","volume":"150","author":"DE Kuhl","year":"1984","unstructured":"Kuhl DE. Imaging local brain function with emission computed tomography.Radiology 1984; 150: 625\u2013631.","journal-title":"Radiology"},{"key":"BF02988596_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410160605","volume":"16","author":"NL Foster","year":"1984","unstructured":"Foster NL, Chase TN, Mansi L, et al. Cortical abnormalities in Alzheimer\u2019s disease.Ann Neurol 1984; 16: 649\u2013654.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR10","first-page":"211","volume":"63","author":"DE Kuhl","year":"1985","unstructured":"Kuhl DE, Metter EJ, Riege WH. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer\u2019s disease.Res Pub Assoc Res Nerv Ment Dis 1985; 63: 211\u2013226.","journal-title":"Res Pub Assoc Res Nerv Ment Dis"},{"key":"BF02988596_CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410180305","volume":"18","author":"NR Cutler","year":"1985","unstructured":"Cutler NR, Haxby JV, Duara R, et al. Clinical history, brain metabolism, and neuropsychological function in Alzheimer\u2019s disease.Ann Neurol 1985; 18: 298\u2013309.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(85)90543-9","volume":"53","author":"RP Friedland","year":"1985","unstructured":"Friedland RP, Budinger TF, Koss E, Ober BA. Alzheimer\u2019s disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.Neurosci Lett 1985; 53: 235\u2013240.","journal-title":"Neurosci Lett"},{"key":"BF02988596_CR13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.36.7.879","volume":"36","author":"R Duara","year":"1986","unstructured":"Duara R, Grady C, Haxby JV, et al. PET in Alzheimer\u2019s disease.Neurology 1986; 36: 879\u2013887.","journal-title":"Neurology"},{"key":"BF02988596_CR14","first-page":"597","volume":"134","author":"PL McGeer","year":"1986","unstructured":"McGeer PL, Kamo H, Harrop R, et al. Positron emission tomography in patients with clinically diagnosed Alzheimer\u2019s disease.Can Med Assoc J Neurol Neurosurg Psychiatry 1986; 134: 597\u2013607.","journal-title":"Can Med Assoc J Neurol Neurosurg Psychiatry"},{"key":"BF02988596_CR15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jnnp.50.6.752","volume":"50","author":"RJ Polinsky","year":"1987","unstructured":"Polinsky RJ, Noble H, Di Chiro G, Nee LE, Feldman RG, Brown RT. Dominantly inherited Alzheimer\u2019s disease: cerebral glucose metabolism.J Neurol Neurosurg Psychiatry 1987; 50: 752\u2013757.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02988596_CR16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archneur.1988.00520280038013","volume":"45","author":"KA Johnson","year":"1988","unstructured":"Johnson KA, Holman BL, Mueller SP, et al. Single photon emission computed tomography in Alzheimer\u2019s disease: abnormal iofetamine I 123 uptake reflects dementia severity.Arch Neurol 1988; 45: 392\u2013396.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR17","first-page":"156","volume":"1","author":"K Herholz","year":"1990","unstructured":"Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss WD. Criteria for the diagnosis of Alzheimer\u2019s disease with PET.Dementia 1990; 1: 156\u2013164.","journal-title":"Dementia"},{"key":"BF02988596_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1991.tb00192.x","volume":"640","author":"WD Heiss","year":"1991","unstructured":"Heiss WD, Szelies B, Kessler J, Herholz K. Abnormalities of energy metabolism in Alzheimer\u2019s disease studies with PET.Ann NY Acad Sci 1991; 640: 65\u201371.","journal-title":"Ann NY Acad Sci"},{"key":"BF02988596_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002093-199100540-00001","volume":"5","author":"BH Guze","year":"1991","unstructured":"Guze BH, Hoffman JM, Baxter LR Jr, Mazziota JC, Phelps ME. Functional brain imaging and Alzheimer-type dementia.Alzheimer Dis Assoc Disord 1991; 5: 215\u2013230.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"BF02988596_CR20","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.54.8.672","volume":"54","author":"H Nyback","year":"1991","unstructured":"Nyback H, Nyman H, Blomqvist G, Sjorgren I, Stone-Elander S. Brain metabolism in Alzheimer\u2019s dementia: studies of11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.J Neurol Neurosurg Psychiatry 1991; 54: 672\u2013678.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02988596_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0197-4580(92)90015-P","volume":"13","author":"R Mielke","year":"1992","unstructured":"Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.Neurobiol Aging 1992; 13: 93\u201398.","journal-title":"Neurobiol Aging"},{"key":"BF02988596_CR22","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.J Nucl Med 1995; 36: 1238\u20131248.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.7326\/0003-4819-101-3-355","volume":"101","author":"NR Cutler","year":"1984","unstructured":"Cutler NR, Duara R, Creasey H, et al. NIH Conference. Brain imaging: aging and dementia.Ann Intern Med 1984; 101: 355\u2013369.","journal-title":"Ann Intern Med"},{"key":"BF02988596_CR24","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1176\/ajp.142.5.638","volume":"142","author":"E Koss","year":"1985","unstructured":"Koss E, Friedland RP, Ober BA, Jagust WJ. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.Am J Psychiatry 1985; 142: 638\u2013640.","journal-title":"Am J Psychiatry"},{"key":"BF02988596_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100029930","volume":"17","author":"EG McGeer","year":"1990","unstructured":"McGeer EG, Peppard RP, McGeer PL, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography studies in presumed Alzhemmer cases, including 13 serial scans.Can J Neurol Sci 1990; 17: 1\u201311.","journal-title":"Can J Neurol Sci"},{"key":"BF02988596_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-3956(90)90050-Z","volume":"24","author":"A Kumar","year":"1990","unstructured":"Kumar A, Scapiro MB, Haxby JV, Grady CL, Friedland RP. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.J Psychiatr Res 1990; 24: 97\u2013109.","journal-title":"J Psychiatr Res"},{"key":"BF02988596_CR27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.1990.00530070043010","volume":"47","author":"JV Haxby","year":"1990","unstructured":"Haxby JV, Grady CL, Koss E, et al. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type.Arch Neurol 1990; 47: 753\u2013760.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archneur.1992.00530350056020","volume":"49","author":"GS Smith","year":"1992","unstructured":"Smith GS, Leon ML, George AE, et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer\u2019s disease. Pathophysiologic implications.Arch Neurol 1992; 49: 1142\u20131150.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-3956(95)00032-1","volume":"30","author":"DRP Brown","year":"1996","unstructured":"Brown DRP, Hunter R, Wyper DJ, et al. Longitudinal changes in cognitive function and regional cerebral function in Alzheimer\u2019s disease: a SPECT blood flow study.J Psychiatr Res 1996; 30: 109\u2013126.","journal-title":"J Psychiatr Res"},{"key":"BF02988596_CR30","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/jnnp.64.6.742","volume":"64","author":"M Lehtovirta","year":"1998","unstructured":"Lehtovirta M, Kuikka J, Helisalmi S, et al. Longitudinal SPECT study in Alzheimer\u2019s disease: relation to apolipoprotein E polymorphism.J Neurol Neurosurg Psychiatry 1998; 64: 742\u2013746.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02988596_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00367450","volume":"223","author":"A Brun","year":"1976","unstructured":"Brun A, Gustafson L. Distribution of cerebral degeneration in Alzheimer\u2019s disease. A clinico-pathological study.Arch Psychiat Nervenkr 1976; 223: 15\u201333.","journal-title":"Arch Psychiat Nervenkr"},{"key":"BF02988596_CR32","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","volume":"225","author":"BT Hyman","year":"1984","unstructured":"Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation.Science 1984; 225: 1168\u20131170.","journal-title":"Science"},{"key":"BF02988596_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological staging of Alzheimer-related changes.Acta Neuropathologica 1991; 82: 239\u2013256.","journal-title":"Acta Neuropathologica"},{"key":"BF02988596_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Brank E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes.Neurobiol Aging 1995; 16: 271\u2013284.","journal-title":"Neurobiol Aging"},{"key":"BF02988596_CR35","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla T, Price TL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease.J Neuroscience 1996; 16: 4491\u20134500.","journal-title":"J Neuroscience"},{"key":"BF02988596_CR36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.49.3.786","volume":"49","author":"CR Jack","year":"1997","unstructured":"Jack CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer\u2019s disease.Neurology 1997; 49: 786\u2013794.","journal-title":"Neurology"},{"key":"BF02988596_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(05)74869-8","volume":"353","author":"M Bobinski","year":"1999","unstructured":"Bobinski M, Leon MJ, Convit A, et al. MRI of entorhinal cortex in mild Alzheimer\u2019s disease.Lancet 1999; 353: 38\u201340.","journal-title":"Lancet"},{"key":"BF02988596_CR38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1212\/WNL.37.7.1119","volume":"37","author":"FJ Huff","year":"1987","unstructured":"Huff FJ, Becker JT, Bell SH, Nebes RD, Holland AL, Boller F. Cognitive deficits and clinical diagnosis of Alzheimer\u2019s disease.Neurology 1987; 37: 1119\u20131124.","journal-title":"Neurology"},{"key":"BF02988596_CR39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archneur.1992.00530290030008","volume":"49","author":"KA Welsh","year":"1992","unstructured":"Welsh KA, Butters N, Hughes JP, Mohs RC, Heyman A. Detection and staging of demential in Alzheimer\u2019s disease: use of the neuropsychological measures developed for the consortium to establish a registry for Alzheimer\u2019s disease.Arch Neurol 1992; 49: 448\u2013452.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archpsyc.1992.01820050066012","volume":"49","author":"GD Pearlson","year":"1992","unstructured":"Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer\u2019s disease.Arch Gen Psychiatry 1992; 49: 402\u2013408.","journal-title":"Arch Gen Psychiatry"},{"key":"BF02988596_CR41","first-page":"1163","volume":"36","author":"T Ohnishi","year":"1995","unstructured":"Ohnishi T, Hoshi H, Nagamachi S, et al. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases.J Nucl Med 1995; 36: 1163\u20131169.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR42","first-page":"914","volume":"38","author":"P Julin","year":"1997","unstructured":"Julin P, Lindqvist J, Svensson L, Slomka P, Wahlund LO. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzhemer\u2019s disease.J Nucl Med 1997; 38: 914\u2013919.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR43","first-page":"522","volume":"40","author":"G Rodriguez","year":"1999","unstructured":"Rodriguez G, Nobili F, Copello F, et al.99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer\u2019s disease: a correlative study.J Nucl Med 1999; 40: 522\u2013529.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR44","first-page":"1155","volume":"41","author":"D Kogure","year":"2000","unstructured":"Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer\u2019s disease using brain perfusion SPECT.J Nucl Med 2000; 41: 1155\u20131162.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR45","first-page":"299","volume":"10","author":"N Kitayama","year":"1999","unstructured":"Kitayama N, Kogure D, Ohnishi T, et al. MRI-based volumetry of hippocampal gray-matter, and SPECT measurements of hippocampal blood flow for the diagnosis of Alzheimer\u2019s disease: comparison with Statistical Parametric Mapping.Brain Science and Mental Disorders 1999; 10: 299\u2013306.","journal-title":"Brain Science and Mental Disorders"},{"key":"BF02988596_CR46","first-page":"1159","volume":"37","author":"K Ishii","year":"1996","unstructured":"Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer\u2019s disease shown by PET.J Nucl Med 1996; 37: 1159\u20131165.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR47","first-page":"293","volume":"39","author":"K Ishii","year":"1998","unstructured":"Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer\u2019s disease.J Nucl Med 1998; 39: 293\u2013298.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/exnr.1997.6524","volume":"146","author":"HS Dhillon","year":"1997","unstructured":"Dhillon HS, Dose JM, Scheff SW, Prasad MR. Time course of changes in lactate and free fatty acids after experimental brain injury and relationship to morphologic damage.Exp Neurol 1997; 146: 240\u2013249.","journal-title":"Exp Neurol"},{"key":"BF02988596_CR49","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(94)92871-1","volume":"344","author":"S Minoshima","year":"1994","unstructured":"Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer\u2019s disease.Lancet 1994; 344: 895.","journal-title":"Lancet"},{"key":"BF02988596_CR50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease.Ann Neurol 1997; 42: 85\u201394.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR51","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.50.6.1563","volume":"50","author":"KA Johnson","year":"1998","unstructured":"Johnson KA, Jones BL, Holman JA, et al. Preclinical prediction of Alzheimer\u2019s disease using SPECT.Neurology 1998; 50: 1563\u20131571.","journal-title":"Neurology"},{"key":"BF02988596_CR52","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.50.6.1585","volume":"50","author":"V Ibanez","year":"1998","unstructured":"Ibanez V, Pietrini P, Alexandar GE, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer\u2019s disease.Neurology 1998; 50: 1585\u20131593.","journal-title":"Neurology"},{"key":"BF02988596_CR53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jama.1995.03520360056039","volume":"273","author":"GW Small","year":"1995","unstructured":"Small GW, Mazziotta JC, Collins MT, et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.JAMA 1995; 273: 942\u2013947.","journal-title":"JAMA"},{"key":"BF02988596_CR54","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.090106797","volume":"97","author":"GW Small","year":"2000","unstructured":"Small GW, Ercoli LM, Silverman DH, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer\u2019s disease.Proc Natl Acad Sci USA 2000; 97: 6037\u20136042.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02988596_CR55","first-page":"493","volume-title":"Positron Emission Tomography and Autoradiography","author":"JC Mazziota","year":"1986","unstructured":"Mazziota JC, Phelps ME. Principles and Applications for the Brain and Heat. InPositron Emission Tomography and Autoradiography, Phelps ME, Mazziota JC, Schelbert H (eds), New York; Raven Press, 1986: 493\u2013579."},{"key":"BF02988596_CR56","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/brain\/122.8.1519","volume":"122","author":"K Meguro","year":"1999","unstructured":"Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer\u2019s disease.Brain 1999; 122: 1519\u20131531.","journal-title":"Brain"},{"key":"BF02988596_CR57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/brain\/121.4.611","volume":"121","author":"B Desgranges","year":"1998","unstructured":"Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer\u2019s disease. A PET study of resting brain glucose utilization.Brain 1998; 121: 611\u2013631.","journal-title":"Brain"},{"key":"BF02988596_CR58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/brain\/118.2.401","volume":"118","author":"PC Fletcher","year":"1995","unstructured":"Fletcher PC, Frith CD, Grasby PM, Shallice T, Frackwiak RSJ, Dolan RJ. Brain system for encoding and retrieval of auditory-verbal memory.Brain 1995; 118: 401\u2013416.","journal-title":"Brain"},{"key":"BF02988596_CR59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/114.1.349","volume":"114","author":"P Rudge","year":"1991","unstructured":"Rudge P, Warrington EK. Selective impairment of memory and visual perception in splenial tumours.Brain 1991; 114: 349\u2013360.","journal-title":"Brain"},{"key":"BF02988596_CR60","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/110.6.1631","volume":"110","author":"E Valenstein","year":"1987","unstructured":"Valenstein E, Bowers D, Verfaellie M, Heilman KM, Day A, Watson RT. Retrosplenial amnesia.Brain 1987; 110: 1631\u20131646.","journal-title":"Brain"},{"key":"BF02988596_CR61","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archneurpsyc.1937.02260220069003","volume":"38","author":"JW Papez","year":"1937","unstructured":"Papez JW. A proposed mechanism of emotion.Arch Neurol Psychiatry 1937; 38: 725\u2013743.","journal-title":"Arch Neurol Psychiatry"},{"key":"BF02988596_CR62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/brain\/122.3.383","volume":"122","author":"RJ Perry","year":"1999","unstructured":"Perry RJ, Hodges JR. Attention and executive deficits in Alzheimer\u2019s disease. A critical review.Brain 1999; 122: 383\u2013404.","journal-title":"Brain"},{"key":"BF02988596_CR63","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.54.10.1954","volume":"54","author":"M Rizzo","year":"2000","unstructured":"Rizzo M, Anderson SW, Dawson J, Myers R, Ball K. Visual attention impairments in Alzheimer\u2019s disease.Neurology 2000; 54: 1954\u20131959.","journal-title":"Neurology"},{"key":"BF02988596_CR64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1162\/089892900562093","volume":"12","author":"T Iidaka","year":"2000","unstructured":"Iidaka T, Anderson ND, Kapur S, Cabeza R, Craok FI. The effect of divided attention on encoding and retrieval in episodic memory revealed by positron emission tomography.J Cogn Neurosci 2000; 12: 267\u2013280.","journal-title":"J Cogn Neurosci"},{"key":"BF02988596_CR65","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1523\/JNEUROSCI.11-08-02383.1991","volume":"11","author":"M Corbetta","year":"1991","unstructured":"Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Pertersen SE. Selective and divided attention during Visual Discrimination of shape, color, and speed: functional anatomy by positron emission tomography.J Neurosci 1991; 11: 2383\u20132402.","journal-title":"J Neurosci"},{"key":"BF02988596_CR66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1097-0193(1997)5:6<389::AID-HBM1>3.0.CO;2-#","volume":"5","author":"DJ Madden","year":"1997","unstructured":"Madden DJ, Turkington TG, Provenzale JM, Hawk TC, Hoffman JM, Coleman RE. Selective and divided visual attention: Age-Related changes in regional cerebral blood flow measured by H2 15O PET.Hum Brain Map 1997; 5: 389\u2013409.","journal-title":"Hum Brain Map"},{"key":"BF02988596_CR67","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archneur.1983.04050110029003","volume":"40","author":"DF Benson","year":"1983","unstructured":"Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. The fluorodeoxyglucose18F scan in Alzheimer\u2019s disease and multi-infarct dementia.Arch Neurol 1983; 40: 711\u2013714.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR68","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004728-199507000-00006","volume":"19","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis.J Comput Assist Tomogr 1995; 19: 541\u2013547.","journal-title":"J Comput Assist Tomogr"},{"key":"BF02988596_CR69","first-page":"925","volume":"38","author":"K Ishii","year":"1997","unstructured":"Ishii K, Sasaki M, Kitagaki H, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer\u2019s disease.J Nucl Med 1997; 38: 925\u2013928.","journal-title":"J Nucl Med"},{"key":"BF02988596_CR70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber KH. Apolipoprotein E: Structure-function relationship.Adv Protein Chem 1994; 45: 249\u2013302.","journal-title":"Adv Protein Chem"},{"key":"BF02988596_CR71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.Science 1993; 261: 921\u2013923.","journal-title":"Science"},{"key":"BF02988596_CR72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000154384","volume":"47","author":"Z Yamagata","year":"1996","unstructured":"Yamagata Z, Asada T, Kinoshita A, et al. Distribution of apolipoprotein E gene polymorphisms in Japanese patients with Alzheimer\u2019s disease and in Japanese centenarians.Hum Hered 1996; 47: 22\u201326.","journal-title":"Hum Hered"},{"key":"BF02988596_CR73","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0306-4522(95)00331-C","volume":"69","author":"Z Nagy","year":"1995","unstructured":"Nagy Z, Esiri MM, Jobst KA, et al. Influence of the Apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer\u2019s disease.Neuroscience 1995; 69: 757\u2013761.","journal-title":"Neuroscience"},{"key":"BF02988596_CR74","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","volume":"333","author":"T Polvikoski","year":"1995","unstructured":"Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of \u03b2-amyloid protein.N Engl J Med 1995; 333: 1242\u20131247.","journal-title":"N Engl J Med"},{"key":"BF02988596_CR75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.Nature Genet 1997; 17: 263\u2013264.","journal-title":"Nature Genet"},{"key":"BF02988596_CR76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.N Engl J Med 1996; 334: 752\u2013758.","journal-title":"N Engl J Med"},{"key":"BF02988596_CR77","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.51.1.149","volume":"51","author":"S Craft","year":"1998","unstructured":"Craft S, Teri L, Edland SD, Kukull WA, et al. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer\u2019s disease.Neurology 1998; 51: 149\u2013153.","journal-title":"Neurology"},{"key":"BF02988596_CR78","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.47.2.444","volume":"47","author":"JH Growdon","year":"1996","unstructured":"Growdon JH, Locascio JJ, Corkin S, et al. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer\u2019s disease.Neurology 1996; 47: 444\u2013448.","journal-title":"Neurology"},{"key":"BF02988596_CR79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.410390110","volume":"39","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer\u2019s disease.Ann Neurol 1996; 39: 62\u201370.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s004150050351","volume":"246","author":"AJ Slooter","year":"1999","unstructured":"Slooter AJ, Houwing-Duistermaat JJ, van Harskamp F, et al. Apolipoprotein E genotype and progression of Alzheimer\u2019s disease: the Rotterdam Study.J Neurol 1999; 246: 304\u2013308.","journal-title":"J Neurol"},{"key":"BF02988596_CR81","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.1997.00550150035013","volume":"54","author":"EH Corder","year":"1997","unstructured":"Corder EH, Jelic V, Basun H, et al. No difference in cerebral glucose metabolism in patients with Alzheimer\u2019s disease and differing apolipoprotein E genotypes.Arch Neurol 1997; 54: 273\u2013277.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00002093-199812000-00018","volume":"12","author":"N Hirono","year":"1998","unstructured":"Hirono N, Mori E, Yasuda M, Ishii K, et al. Lacl of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.Alzheimer Dis Assoc Disord 1998; 12: 362\u2013367.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"BF02988596_CR83","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ana.410370509","volume":"37","author":"GB Frisoni","year":"1995","unstructured":"Frisoni GB, Govoni S, Geroldi C, et al. Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer\u2019s disease.Ann Neurol 1995; 37: 596\u2013604.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR84","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archneur.55.11.1460","volume":"55","author":"CH Dyck van","year":"1998","unstructured":"van Dyck CH, Gelemter J, MacAvoy MG, et al. Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.Arch Neurol 1998; 55: 1460\u20131466.","journal-title":"Arch Neurol"},{"key":"BF02988596_CR85","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ana.410410510","volume":"41","author":"Y Stern","year":"1997","unstructured":"Stern Y, Brandt J, Albert M, et al. The absence of an apolipoprotein \u03b54 allele is associated with a more aggressive form of Alzheimer disease.Ann Neurol 1997; 41: 615\u2013620.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR86","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/WNL.45.2.391","volume":"45","author":"H Soininen","year":"1995","unstructured":"Soininen H, Partanen K, Pitkanen A, et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E \u03b54 allele.Neurology 1995; 45: 391\u2013392.","journal-title":"Neurology"},{"key":"BF02988596_CR87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(97)00743-X","volume":"236","author":"H Tohgi","year":"1997","unstructured":"Tohgi H, Takahashi S, Kato E, et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E \u03b54 allele.Neurosci Lett 1997; 236: 21\u201324.","journal-title":"Neurosci Lett"},{"key":"BF02988596_CR88","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/jnnp.60.6.644","volume":"60","author":"M Lehtovirta","year":"1996","unstructured":"Lehtovirta M, Soininen H, Laakso MP, et al. SPECT and MRI analysis in Alzheimer\u2019s disease: relation to the apolipoprotein E \u03b54 allele.J Neurol Neurosurg, Psychiatry 1996; 60: 644\u2013649.","journal-title":"J Neurol Neurosurg, Psychiatry"},{"key":"BF02988596_CR89","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0140-6736(94)90799-4","volume":"344","author":"H Arai","year":"1994","unstructured":"Arai H, Higuchi S, Muramatsu T, Iwatsubo T, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer\u2019s disease.Lancet 1994; 344: 1307.","journal-title":"Lancet"},{"key":"BF02988596_CR90","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.47.2.462","volume":"47","author":"RL Albin","year":"1996","unstructured":"Albin RL, Minoshima S, D\u2019Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.Neurology 1996; 47: 462\u2013466.","journal-title":"Neurology"},{"key":"BF02988596_CR91","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmar AM, Snape M, Wlcock GK. The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress.J Neurol Neurosurg Psychiatry 1999; 66: 137\u2013147.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02988596_CR92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.50.1.136","volume":"50","author":"SL Rogers","year":"1998","unstructured":"Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer\u2019s disease.Neurology 1998; 50: 136\u2013145.","journal-title":"Neurology"},{"key":"BF02988596_CR93","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.158.9.1021","volume":"158","author":"SL Rogers","year":"1998","unstructured":"Rogers SL, Doody RS, Mohs R, et al. Donepezil improves cognition and global function in Alzheimer disease.Arch Intern Med 1998; 158: 1021\u20131031.","journal-title":"Arch Intern Med"},{"key":"BF02988596_CR94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/jon199884249","volume":"8","author":"S Warren","year":"1998","unstructured":"Warren S, Hier DB, Pavel D. Visual form of Alzheimer\u2019s disease and its response to anticholinesterase therapy.J Neuroimaging 1998; 8: 249\u2013252.","journal-title":"J Neuroimaging"},{"key":"BF02988596_CR95","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1176\/appi.neuropsych.12.2.209","volume":"12","author":"MS Mega","year":"2000","unstructured":"Mega MS, Dinov ID, Lee L, et al. Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer\u2019s disease.J Neuropsychiatry Clin Neurosic 2000; 12: 209\u2013218.","journal-title":"J Neuropsychiatry Clin Neurosic"},{"key":"BF02988596_CR96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00006231-200001000-00007","volume":"21","author":"RT Staff","year":"2000","unstructured":"Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A. Changes in the rCBF images of patients with Alzheimer\u2019s disease receiving Donepezil therapy.Nucl Med Commun 2000; 21: 37\u201341.","journal-title":"Nucl Med Commun"},{"key":"BF02988596_CR97","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0969-8051(94)90159-7","volume":"21","author":"T Irie","year":"1994","unstructured":"Irie T, Fukushi K, Akimoto Y, et al. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE)in vivo.Nucl Med Biol 1994; 21: 801\u2013808.","journal-title":"Nucl Med Biol"},{"key":"BF02988596_CR98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1212\/WNL.52.4.691","volume":"52","author":"DE Kuhl","year":"1999","unstructured":"Kuhl DE, Koeppe RA, Minoshima S, et al.In vivo mapping of cerebral acetylcholinestrase activity in aging and Alzheimer\u2019s disease.Neurology 1999; 52: 691\u2013699.","journal-title":"Neurology"},{"key":"BF02988596_CR99","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1531-8249(200008)48:2<194::AID-ANA9>3.0.CO;2-X","volume":"48","author":"H Shinotoh","year":"2000","unstructured":"Shinotoh H, Namba H, Fukushi K, et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer\u2019s disease: a positron emission tomography study.Ann Neurol 2000; 48: 194\u2013200.","journal-title":"Ann Neurol"},{"key":"BF02988596_CR100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1531-8249(200009)48:3<391::AID-ANA17>3.0.CO;2-H","volume":"48","author":"DE Kuhl","year":"2000","unstructured":"Kuhl DE, Minoshima S, Frey KA, Foster NL, Kolbourn MR, Koeppe RA. Limited donepezil inhibition of acetylcholinesterase measured by positron emission tomography in living Alzheimer cerebral cortex.Ann Neurol 2000; 48: 391\u2013395.","journal-title":"Ann Neurol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02988596\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T19:56:10Z","timestamp":1558554970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02988596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["BF02988596"],"URL":"https:\/\/doi.org\/10.1007\/bf02988596","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}